Enrolling by invitationNot applicableNCT07250113
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT
Studying NON RARE IN EUROPE: Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northwell Health
- Principal Investigator
- Liron Sinvani, MDNorthwell Health
- Intervention
- WeCareToFeedDysphagia web tool(behavioral)
- Enrollment
- 802 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2028
Study locations (1)
- The Feinstein Institutes for Medical Research, Manhasset, New York, United States
Collaborators
National Institute on Aging (NIA) · National Institutes of Health (NIH)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07250113 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Alzheimer disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07457138Lombard Cohort of Brain Health ServicesUniversity of Milano Bicocca
- RECRUITINGNANCT07286448Personalized Digital Training for COGnitive FITness in Mild Cognitive ImpairmentGiovanna Zamboni
- ACTIVE NOT RECRUITINGNANCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceUniversity of Milano Bicocca
- RECRUITINGNANCT07212504Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory ProblemsRotman Research Institute at Baycrest
- ENROLLING BY INVITATIONNANCT07168824An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionChi-Chang Huang
- RECRUITINGNCT07402161The Signature of Alzheimer's Disease in Subjective Cognitive DeclineIRCCS Policlinico S. Donato
- ACTIVE NOT RECRUITINGNANCT07350226Electro-acupuncture for SCD With DepressionThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGPHASE2NCT07105709Open-label Extension Study in Participants With Early Alzheimer's DiseaseGlaxoSmithKline